Recent evidence suggests that this deficiency is partly driven by epigenetic programming and that targeting epigenetic regulators, such as EZH2, LSD1, and MEN1, can induce MHC-I in SCLC [4, 10–12]. Here, EZH2 is linked to small cell lung carcinoma.